NCT01082120View on ClinicalTrials.gov

Investigate the Effect of AZD1656 on the Pharmacokinetics of Pioglitazone and Vice Versa in Type 2 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

AZD1656

Tablets orally, twice daily for 10 days

DRUG

Pioglitazone

Tablet oral single dose for 10 days

Trial Locations (1)

Unknown

Research Site, Chula Vista

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY